Pfizer (PFE) scored the top spot in Interbrand Health's inaugural ranking of the top ten biopharmaceutical brands. The ranking uses analytics to quantify the measurable, financial impact that a company's brand has on its overall business performance. After Pfizer, the top ranked brands in order were Roche/Genentech, Merck/MSD (MRK) , Johnson & Johnson's (JNJ) Janssen unit, Novartis (NVS) , Amgen (AMGN) , Gilead (GILD) , Novo Nordisk, AstraZeneca (AZN) , and GSK (GSK) . InterbrandHealth said corporate branding is an undervalued asset, and the Best Pharma Brands report demonstrates how a company's corporate brand influences decisions made by health care providers.
Scroll to Continue